Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA
Ad hoc announcement pursuant to Art. 53 LR The Phase III STEER…
50% of Older Adults to Rely on Wearables for Life-Saving Alerts by 2034, ScienceSoft Predicts
MCKINNEY, Texas--(BUSINESS WIRE)--ScienceSoft has released its proprietary research exploring the potential of…
Nxera Pharma and Shionogi Launch QUVIVIQ in Japan for Adults with Insomnia
December 18, 2024 21:35 ET | Source: Nxera Pharma Tokyo, Japan and…
Worldwide English Proficiency Index Reports Persistent Global Decline With Weaker Skills in Women and Young adults
ZURICH, Nov. 13, 2024 /PRNewswire/ -- EF Education First (EF), a global provider of…
